CHEMFABNSEChemfab Alkalis LimitedHighNeutral
Announced Thu, 12 Feb · 10:05 IST

Chemfab Alkalis Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Revenue DeclinePat NegativeEbitda Margin CompressionResults View source PDFExplain this filing

CHEMFAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹402.00
prior close
₹397.65
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7-0.2-0.4+0.1+2.0-5.5-3.0-2.4-3.5-4.2-6.2-5.8-2.9+6.3
Up moveDown movePending
AI summary

Chemfab Alkalis reported a weak set of numbers for Q3 FY26 (quarter ended December 31, 2025). Standalone revenue from operations fell to ₹6,185.38 lakhs, down about 22% from ₹7,920.54 lakhs in the same quarter last year. The company swung to a standalone net loss of ₹103.80 lakhs in Q3 FY26 versus a profit of ₹401.76 lakhs in Q3 FY25, with loss before tax of ₹138.33 lakhs. For the nine-month period, standalone revenue declined about 6% to ₹21,983.99 lakhs and net profit dropped roughly 47% to ₹594.62 lakhs. On a consolidated basis, Q3 FY26 revenue fell to ₹6,814.45 lakhs and the company reported a loss before tax of ₹479.33 lakhs, compared to a profit of ₹364.19 lakhs last year. The PVC-O Pipes segment was the main drag, with segment profit falling sharply from ₹938.76 lakhs to ₹66.62 lakhs quarter-on-quarter, while the Chemicals segment continued to post losses though narrower than the year-ago quarter. Deloitte Haskins & Sells LLP issued an unmodified review report for both standalone and consolidated results.

Likely market impact

Weak Q3 results with a clear revenue decline and a swing to losses are likely to weigh on short-term investor sentiment and could pressure the stock price. Investors should watch the PVC-O Pipes segment closely as it accounts for most of the deterioration.